SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000899923-21-000063
Filing Date
2021-08-04
Accepted
2021-08-04 16:06:34
Documents
88
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mygn-20210630.htm   iXBRL 10-Q 1723074
2 EX-31.1 exhibit311-certificationof.htm EX-31.1 10541
3 EX-31.2 exhibit312-certificationof.htm EX-31.2 10557
4 EX-32.1 exhibit321-certificationpu.htm EX-32.1 6379
  Complete submission text file 0000899923-21-000063.txt   8473841

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mygn-20210630.xsd EX-101.SCH 51611
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mygn-20210630_cal.xml EX-101.CAL 100577
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mygn-20210630_def.xml EX-101.DEF 250273
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mygn-20210630_lab.xml EX-101.LAB 699257
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mygn-20210630_pre.xml EX-101.PRE 445612
10 EXTRACTED XBRL INSTANCE DOCUMENT mygn-20210630_htm.xml XML 1655069
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26642 | Film No.: 211144012
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences